Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer
暂无分享,去创建一个
I. Chabot | A. Kadambi | Yun Su | B. Neupane | M. Betts | Rachel Hughes | Qi Zhao | K. Mickle